Kentucky SB 192: AN ACT relating to the monitoring of controlled substances. Amend KRS 218A.010 to modify a definition; amend KRS 218A.020 to require that controlled substances scheduled by the federal Controlled Substances Act be regulated in the same schedule as the federal schedule; establish a method to schedule in a more restrictive schedule at the state level; amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to CHFS; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240, 243.100, 243.390, 243.500, and 314.011 to conform; repeal KRS 218A.030, 218A.050, 218A.070, 218A.090, 218A.110, and 218A.130, relating to the previous controlled substances scheduling system.

Status: To Health & Welfare (S) (as of 2017-02-15)

State: Kentucky · Session: 2017RS · Bill: SB 192

View Kentucky SB 192 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.